Stressed-Plant Terpenoid Cannabinoid Blends for Addiction Withdrawal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for opioid, cannabinoid, and cocaine addiction, as well as self-drug dependence, are either ineffective or come with significant side effects and the risk of addiction, and there is a lack of effective alternatives for managing chronic pain and degenerative diseases.
Innovation Solution
Development of terpenoids and cannabinoids extracted from stressed plants, specifically under four delta-different natural stresses, which interact with the brain's reward centers to modulate MOR signaling and stabilize the gastrointestinal-central nervous-immune system homeostasis, offering a non-addictive treatment for addiction and pain relief.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments for opioid, cannabinoid, and cocaine addiction are used, then addiction symptoms are addressed, but significant side effects and risk of addiction occur
Solution Approach 1:
The patent applies parameter changes by utilizing terpenoids and cannabinoids extracted from plants under four distinct stress levels (delta-s, delta-m, delta-l, and delta-ol). This variation in extraction conditions creates different compositional parameters of the final product, optimizing therapeutic effectiveness while minimizing harmful side effects and addiction risk associated with conventional treatments
Solution Approach 2:
The invention employs composite materials by combining multiple terpenoid and cannabinoid compounds extracted from stressed plants. The formulation includes various terpenes (myrcene, limonene, pinene, linalool, caryophyllene) and cannabinoids (CBD, CBG, CBC, THCV) that work synergistically to treat addiction effectively while reducing the harmful effects associated with single-compound conventional treatments
2Reliability
If effective alternatives for managing chronic pain and degenerative diseases are needed, then new treatments must be developed, but current options are limited or ineffective
Solution Approach 1:
The patent demonstrates universality by showing that the terpenoid-cannabinoid composition extracted from stressed plants can treat multiple conditions including opioid addiction, cannabinoid addiction, cocaine addiction, chronic pain, and degenerative diseases. This multi-functional approach addresses the limited availability of treatment options by providing a single versatile therapeutic solution
Solution Approach 2:
The invention utilizes parameter changes by extracting compounds from plants subjected to four different stress levels, creating variations in the chemical composition that can be optimized for different therapeutic applications. This allows the same base formulation to be adapted for treating diverse conditions ranging from addiction to chronic pain to degenerative diseases
3Reliability
If terpenoids and cannabinoids are extracted from stressed plants under four delta-different natural stresses, then brain's reward centers are modulated and homeostasis is stabilized, but extraction complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the extraction process into four distinct stages corresponding to four different plant stress levels (delta-s, delta-m, delta-l, and delta-ol). Each stage targets specific terpenoid and cannabinoid compounds that become available under particular stress conditions, allowing systematic collection of compounds that collectively modulate brain reward centers and stabilize homeostasis while managing extraction complexity through structured segmentation
Data Source
AI summary
Cannabinoids and terpenoids, which are non-psychoactive elements found in stressed plants, are being studied as possible supplemental treatments for symptoms of drug withdrawal related to remodeling. The therapeutic properties, in addition to reducing cue-induced drug cravings, are very relevant to opioid, cocaine, or cannabis withdrawal syndromes and should be included in standard detoxification programs to mitigate the symptoms of drug withdrawal. Since there is no way to stop this addiction without suffering from serious adverse effects or developing a self-addiction to pharmacological therapies, opioids, cocaine, and cannabis are extremely addictive substances. Using low-dose mixtures of terpenes, terpenoids, and cannabinoids, this innovation seeks to provide a revolutionary anti-addictive analgesic regimen that will safely and effectively cure individuals who are addicted to opioids, cannabinoids, cocaine, or self-addictive substances. Blocking the effects of addiction by inhibiting physiological metabolic processes, these compounds have safe and effective pharmacological, neurobiological, and psychological mechanisms for curing addiction.